BDBM235341 (3aR,5S,6aS)-5-benzyl-2- ((S)-2-hydroxy-2-(4- hydroxyphenyl)ethyl)octa- hydrocyclopenta[c]pyrrol- 5-ol::US10052306, 137::US10052306, 143

SMILES O[C@H](CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1

InChI Key InChIKey=PFQYYQCYAUKHMU-NPDDRXJXSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 235341   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM235341((3aR,5S,6aS)-5-benzyl-2- ((S)-2-hydroxy-2-(4- hydr...)
Affinity DataIC50:  20.4nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM235341((3aR,5S,6aS)-5-benzyl-2- ((S)-2-hydroxy-2-(4- hydr...)
Affinity DataIC50:  20.4nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent